BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 1173242)

  • 1. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.
    Saberi M; Sterling FH; Utiger RD
    J Clin Invest; 1975 Feb; 55(2):218-23. PubMed ID: 1173242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.
    Geffner DL; Azukizawa M; Hershman JM
    J Clin Invest; 1975 Feb; 55(2):224-9. PubMed ID: 805160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating 3,3', 5'-triiodothyronine (reverse T3) in the human newborn.
    Chopra IJ; Sack J; Fisher DA
    J Clin Invest; 1975 Jun; 55(6):1137-41. PubMed ID: 1133163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypothyroidism on hypothalamic release of thyrotropin-releasing hormone in rats.
    Rondeel JM; de Greef WJ; Klootwijk W; Visser TJ
    Endocrinology; 1992 Feb; 130(2):651-6. PubMed ID: 1733713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil.
    Israel Y; Walfish PG; Orrego H; Blake J; Kalant H
    Gastroenterology; 1979 Jan; 76(1):116-22. PubMed ID: 758132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.
    Nomura S; Pittman CS; Chambers JB; Buck MW; Shimizu T
    J Clin Invest; 1975 Sep; 56(3):643-52. PubMed ID: 1159078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid vascular conductance: differential effects of elevated plasma thyrotropin (TSH) induced by treatment with thioamides or TSH-releasing hormone.
    Connors JM; Huffman LJ; Michalkiewicz M; Chang BS; Dey RD; Hedge GA
    Endocrinology; 1991 Jul; 129(1):117-25. PubMed ID: 1905224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum triiodothyronine (T3) and thyroxine (T4) with biologic effects of thyroid hormone replacement in propylthiouracil-treated rats.
    Frumess RD; Larsen PR
    Metabolism; 1975 Apr; 24(4):547-54. PubMed ID: 1117844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.
    Larsen PR; Dick TE; Markovitz BP; Kaplan MM; Gard TG
    J Clin Invest; 1979 Jul; 64(1):117-28. PubMed ID: 447848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man.
    Chopra IJ
    J Clin Invest; 1976 Jul; 58(1):32-40. PubMed ID: 932209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrathyroidal effects of propylthiouracil and carbimazole on serum T4, T3, reverse T3 and TRH-induced TSH-release in man.
    Siersbaek-Nielsen K; Kirkegaard C; Rogowski P; Faber J; Lumholtz B; Friis T
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):80-7. PubMed ID: 413302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma 3,5,3'-triiodothyronine sulfate in rats with inhibited type I iodothyronine deiodinase activity, as measured by radioimmunoassay.
    Rooda SJ; Kaptein E; Rutgers M; Visser TJ
    Endocrinology; 1989 Feb; 124(2):740-5. PubMed ID: 2912698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.
    Vagenakis AG; Rapoport B; Azizi F; Portnay GI; Braverman LE; Ingbar SH
    J Clin Invest; 1974 Oct; 54(4):913-8. PubMed ID: 4214837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin-releasing hormone on serum concentrations of thyroxine and triiodothyronine in healthy, thyroidectomized, thyroxine-treated, and propylthiouracil-treated dogs.
    Li WI; Chen CL; Tiller AA; Kunkle GA
    Am J Vet Res; 1986 Jan; 47(1):163-9. PubMed ID: 3080928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the biological effects of thyroxine and triiodothyronine in the rat.
    Larsen PR; Frumess RD
    Endocrinology; 1977 Apr; 100(4):980-8. PubMed ID: 556986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thyroid hormone and thyrotropin levels in subjects from endemic goiter regions of New Guinea.
    Chopra IJ; Hershman JM; Hornabrook RW
    J Clin Endocrinol Metab; 1975 Feb; 40(2):326-33. PubMed ID: 1117981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat.
    Männistö PT; Ranta T; Leppäluoto J
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):271-81. PubMed ID: 111448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
    Golden MP; Kaplan SA; Lippe BM; Lee WN
    Pediatrics; 1977 May; 59(5):762-7. PubMed ID: 577011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.